Suchergebnisse - "Ko, Fanny Wai San"

PubPharm (51)

1

Exhaled biomarkers for respiratory diseases

enthalten in: Respirology (Carlton, Vic.) | 2024

von Ko, F.

2

Clinical characteristics and healthcare resource utilization in patients with chronic obstructive pulmonary disease in Hong Kong

enthalten in: Respiratory medicine | 2024

von Ko, F. | Xu, X. | Chau, C. | +3

3

Global mortality and readmission rates following COPD exacerbation-related hospitalisation : a meta-analysis of 65 945 individual patients

enthalten in: ERJ open research | 2024

von Waeijen-Smit, K. | Crutsen, M. | Keene, S. | +52

4

Can we predict asthma exacerbations?

enthalten in: Respirology (Carlton, Vic.) | 2023

von Ko, F.

5

Comparison of the 12-month impact of COVID-19 and SARS on physiological capacity and health-related quality of life

enthalten in: BMC pulmonary medicine | 2023

von Chan, K. | Ng, S. | Lui, G. | +13

6

Comparison of the 12-month impact of COVID-19 and SARS on physiological capacity and health-related quality of life

enthalten in: BMC pulmonary medicine | 2023

von Chan, K. | Ng, S. | Lui, G. | +13

7

Minimize systemic oral corticosteroids use and reduce harm for patients with asthma

enthalten in: Respirology (Carlton, Vic.) | 2023

von Ko, F. | Salvi, S.

CommentOn: Respirology. 2023 Aug;28(8):744-757. - PMID 37301540

8

Smoking : Quit to win

enthalten in: Respirology (Carlton, Vic.) | 2023

von Ko, F.

9

GOLD 2023 executive summary : comments from Asia's perspective

enthalten in: The European respiratory journal | 2023

von Ko, F. | Hui, D.

CommentOn: Eur Respir J. 2023 Apr 1;61(4):. - PMID 36858443

10

Severe asthma, more than that?

enthalten in: Respirology (Carlton, Vic.) | 2023

von Ko, F.

1
2
3
4
5
6
Nächster »
[6]